androsterone glucuronide has been researched along with Atrophy in 1 studies
*Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bélanger, A; Gonthier, R; Ke, Y; Labrie, F; Martel, C; Simard, JN; Vaillancourt, M | 1 |
1 other study(ies) available for androsterone glucuronide and Atrophy
| Article | Year |
|---|---|
Concentration range of serum sex steroids in normal postmenopausal women and those with diagnosis of vulvovaginal atrophy.
Topics: Aged; Androsterone; Atrophy; Case-Control Studies; Clinical Trials as Topic; Dehydroepiandrosterone Sulfate; Estrone; Female; Humans; Mass Spectrometry; Middle Aged; Postmenopause; Testosterone; Vaginal Diseases | 2018 |